Literature DB >> 25356164

A case report on nephrotic syndrome associated with ankylosing spondylitis effectively treated with infliximab.

Xin Feng1, Yao Li2, Wei Gao1.   

Abstract

Renal abnormalities have been reported to occur in patients with ankylosing spondylitis (AS). This study examined a patient who suffered from AS for two years. The 24-hour urine protein of the patient was 4.80 g/day. The result of renal biopsy showed minimal change. The patient was treated with infliximab. After two months, nephrotic syndrome was treated successfully.

Entities:  

Keywords:  Ankylosing spondylitis; infliximab; nephrotic syndrome

Year:  2014        PMID： 25356164      PMCID： PMC4211814     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN： 1940-5901


  7 in total

1.  Infliximab and nephrotic syndrome.

Authors:  George Chin; Grant Luxton; Jennet M Harvey
Journal:  Nephrol Dial Transplant       Date:  2005-10-04       Impact factor: 5.992

2.  Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis.

Authors:  Mehmet Fatih Akdoğan; Murat Gücün; Nazım Denizli; Murat Güney; Ibrahim Akdag; Tevhide Bilgen Ozcan; Murat Duranay
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

3.  [Renal abnormalities in ankylosing spondylitis].

Authors:  Barbouch Samia; Faiçal Hazgui; Khaoula Ben Abdelghani; Fethi Ben Hamida; Rym Goucha; Hafedh Hedri; Chokri Ben Taarit; Hedi Ben Maiz; Adel Kheder
Journal:  Nephrol Ther       Date:  2012-04-18       Impact factor: 0.722

4.  [Renal involvement in ankylosing spondylitis: concerning 210 cases].

Authors:  C Ben Taarit; H Ajlani; F Ben Moussa; T Ben Abdallah; H Ben Maïz; A Khedher
Journal:  Rev Med Interne       Date:  2005-09-30       Impact factor: 0.728

5.  Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome.

Authors:  David Raveh; Ovadia Shemesh; Yaakov Jack Ashkenazi; Robert Winkler; Vivian Barak
Journal:  Pediatr Nephrol       Date:  2004-08-25       Impact factor: 3.714

6.  A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab.

Authors:  Takeshi Kuroda; Yasuhiro Otaki; Hiroe Sato; Takeo Fujimura; Takeshi Nakatsue; Syuichi Murakami; Minoru Sakatsume; Masaaki Nakano; Fumitake Gejyo
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

7.  Membranous glomerulonephritis in a patient with ankylosing spondylitis: a rare association.

Authors:  Ruchika Gupta; Alok Sharma; Raman Arora; Amit K Dinda; Ankur Gupta; Suresh C Tiwari
Journal:  Clin Exp Nephrol       Date:  2009-08-04       Impact factor: 2.801
  7 in total
  1 in total

1.  Elevated serum levels of IL-6 and IL-17 may associate with the development of ankylosing spondylitis.

Authors:  Wei Liu; Yuan-Hao Wu; Lei Zhang; Xiao-Ya Liu; Bin Xue; Yi Wang; Bin Liu; Qiao Jiang; Hou-Wen Kwang; Dong-Jing Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.